These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 15255845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization.
    Van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, Kanhai HH.
    Am J Obstet Gynecol; 2005 Jan; 192(1):171-7. PubMed ID: 15672021
    [Abstract] [Full Text] [Related]

  • 3. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, Kanhai HH.
    Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ, Gómez-Partida G, Guevara-Rubio G, Velázquez-Gómez L.
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [Abstract] [Full Text] [Related]

  • 6. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM, Lindenburg I, van Kamp IL, Meerman RH, Kanhai HH, Oepkes D.
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [Abstract] [Full Text] [Related]

  • 7. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
    Inglis SR, Lysikiewicz A, Sonnenblick AL, Streltzoff JL, Bussel JB, Chervenak FA.
    Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
    Lindenburg IT, van Kamp IL, van Zwet EW, Middeldorp JM, Klumper FJ, Oepkes D.
    BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
    [Abstract] [Full Text] [Related]

  • 13. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
    Lobato G, Soncini CS.
    Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ, Klumper FJ, de Haas M, Meerman RH, van Kamp IL, Oepkes D.
    Obstet Gynecol; 2007 May; 109(5):1093-8. PubMed ID: 17470588
    [Abstract] [Full Text] [Related]

  • 18. Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization.
    Deka D, Dadhwal V, Sharma AK, Shende U, Agarwal S, Agarwal R, Vanamail P.
    Arch Gynecol Obstet; 2016 May; 293(5):967-73. PubMed ID: 26493554
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.